GliaPharm is a Swiss biotechnology company developing treatments for orphan neurological disorders. The company has developed a proprietary platform and pipeline of molecules targeting brain glial cells to restore brain metabolism deficits in orphan diseases linked to brain metabolism dysfunction.


Chemin des Mines 9, 1202 Geneva, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business